Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/130043
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Effects of aspirin on the long-term management of depression in older people: a double-blind randomised placebo-controlled trial
Author: Berk, M.
Agustini, B.
Woods, R.L.
Nelson, M.R.
Shah, R.C.
Reid, C.M.
Storey, E.
Fitzgerald, S.M.
Lockery, J.E.
Wolfe, R.
Mohebbi, M.
Dodd, S.
Murray, A.M.
Stocks, N.
Fitzgerald, P.B.
Mazza, C.
McNeil, J.J.
Citation: Molecular Psychiatry, 2021; :1-10
Publisher: Springer Nature [academic journals on nature.com]
Issue Date: 2021
ISSN: 1359-4184
1476-5578
Statement of
Responsibility: 
Michael Berk, Bruno Agustini, Robyn L. Woods, Mark R. Nelson, Raj C. Shah, Christopher M. Reid ... et al.
Abstract: Late-life depression is common and often inadequately managed using existing therapies. Depression is also associated with increased markers of inflammation, suggesting a potential role for anti-inflammatory agents. ASPREE-D is a sub-study of ASPREE, a large multi-centre, population-based, double-blind, placebo-controlled trial of aspirin vs placebo in older Australian and American adults (median follow-up: 4.7 years) of whom 1879 were depressed at baseline. Participants were given 100 mg daily dose of aspirin or placebo. Depressive symptoms were assessed annually using the validated, self-rated short version of the Center for Epidemiological Studies Depression scale. There was a significant increase in depressive scores (0.6; 95% CI 0.2 to 0.9; χ<sup>2</sup> (1) = 10.37; p = 0.001) and a decreased score in the mental health component of a quality of life scale (-0.7; 95% CI -1.4 to -0.1; χ<sup>2</sup> (1) = 4.74; p = 0.029) in the aspirin group compared to the placebo group. These effects were greater in the first year of follow-up and persisted throughout the study, albeit with small to very small effect sizes. This study failed to demonstrate any benefit of aspirin in the long-term course of depression in this community-dwelling sample of older adults over a 5-year period, and identified an adverse effect of aspirin in the course of depression in those with pre-existing depressive symptoms.
Description: Published: 27 January 2021 OnlinePubl
Rights: © The Author(s), under exclusive licence to Springer Nature Limited 2021.
RMID: 1000033989
DOI: 10.1038/s41380-021-01020-5
Grant ID: http://purl.org/au-research/grants/nhmrc/1127060
http://purl.org/au-research/grants/nhmrc/1081901
http://purl.org/au-research/grants/nhmrc/334047
http://purl.org/au-research/grants/nhmrc/1059660
http://purl.org/au-research/grants/nhmrc/1156072
Appears in Collections:Psychiatry publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.